Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bioimpedance Could Offer "Virtual” Biopsies

By HospiMedica staff writers
Posted on 11 Feb 2008
A new diagnostic technique using bioimpedance spectroscopy is being explored to diagnose quickly and accurately cervical and skin cancers.

Researchers at the Queensland University of Technology (QUT, Brisbane, Australia) developed the new diagnostic technique using a tetrapolar electrode configuration, which has been shown to distinguish between normal squamous epithelium and cervical intra-epithelial neoplasia. More...
Exploring a possible solution to anomalous results of the tetrapolar configuration--manifested in an increase in measured impedance when a low impedance lesion is located between a drive and measurement electrode--the researchers employed bioimpedance mapping using an array of 25 (5x5) electrodes. This array allows 64 individual tetrapolar measurements to be taken on 16 locations giving an impedance map of 49 mm2 on the surface of a tissue sample. Multiple measurements at each location reduce the chance of anomalous results since these can later be identified and excluded.

The researchers found that the technique detected changes inside the cells, changes in cells' membranes, and changes in the space between cells. By putting all the information together, the researchers say it may be possible to diagnose different types of cancer, along with their boundaries. The procedure does not necessitate an anesthetic, and has the potential to be as accurate as other, more time-consuming, expensive techniques. The technique was presented at the 13th International Conference on Electrical Bioimpedance and the 8th Conference on Electrical Impedance Tomography, held during September 2007 in Graz (Austria).

"If a cell's structure has changed, the impedance characteristics change and clinicians can use the changes to diagnose the type of lesion,” said lead investigator Jye Smith, Ph.D., a researcher at the school of physical and chemical sciences. "It offers the possibility of a simple device that can be run over the surface of the skin or internal organ that can quickly, cheaply, and accurately record changes in cellular structure that point to cancerous changes.”

Bioimpedance (or bioelectrical impedance) is a measure of the resistance to the flow of electric current through the tissues. The measurement of the bioimpedance in humans and animals has proved useful as a non-invasive method for measuring such things as blood flow (bioimpedance plethysmography) and body composition (bioelectrical impedance analysis (BIA)).


Related Links:
Queensland University of Technology

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.